EM
UTHR icon

ELCO Management’s United Therapeutics UTHR Stock Holding History

ELCO Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241K Buy
+406
New +$202K 0.12% 144
2025
Q1 		– Sell
-669
Closed -$236K – 164
2024
Q4 		$236K Sell
669
-8
-1% -$2.94K 0.12% 139
2024
Q3 		$243K Sell
677
-53
-7% -$17.9K 0.13% 139
2024
Q2 		$233K Sell
730
-181
-20% -$47.9K 0.14% 131
2024
Q1 		$209K Buy
+911
New +$206K 0.13% 138

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ELCO Management's UTHR Position: Q1 2026 in Review

ELCO Management opened a new position in United Therapeutics (UTHR) in Q1 2026: 406 shares worth $241K. The stake represents 0.12% of the portfolio and ranks #144 among its holdings. This is a return to the name: ELCO Management previously reported a position in UTHR as recently as Q4 2024.

ELCO Management first reported a position in UTHR in Q1 2024 and has held it in 5 quarters since. The position peaked at $243K in Q3 2024. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • ELCO Management held 406 shares of United Therapeutics worth $241K as of Q1 2026.
  • United Therapeutics was a new ELCO Management position in Q1 2026.
  • United Therapeutics made up 0.12% of ELCO Management's portfolio in Q1 2026, its #144 holding.
  • ELCO Management first reported a position in United Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • ELCO Management's United Therapeutics position peaked at $243K in Q3 2024.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on ELCO Management's 13F filing for Q1 2026, filed 24 Apr 2026.